Phosphate and thiophosphate protecting groups
First Claim
Patent Images
1. A method for the preparation of an oligonucleotide compound containing one or more moieties having Formula X:
-
wherein;
each W and X is, independently, O or S;
Y is O or NR2;
Z is a single bond, O or NR2a;
each R1 is, independently C1 to C6 alkyl, C2 to C6 alkenyl, C2 to C6 alkynyl, C3 to C6 cycloalkyl, CN, NO2, Cl, Br, F, I, CF3, OR4, NR5aR5b or phenyl;
or two R1 groups, when on adjacent carbons of the phenyl ring, together form a naphthyl ring that includes said phenyl ring;
each R2 and R2a is, independently, H, C1 to C6 alkyl, C2 to C6 alkenyl, C2 to C6 alkynyl, C3 to C6 cycloalkyl or phenyl;
each R3 is, independently, hydrogen, C1 to C6 alkyl, C2 to C6 alkenyl, C2 to C6 alkynyl, C3 to C6 cycloalkyl or phenyl;
or R2 and one R3, together with the atoms to which they are attached, form a saturated or partially saturated 4 to 7 membered, heterocarbocyclic ring containing one nitrogen atom in the ring;
each R3a is, independently, hydrogen, C1 to C6 alkyl, C2 to C6 alkenyl, C2 to C6 alkynyl, C3 to C6 cycloalkyl or phenyl;
or R2 and R3a, together with the atoms to which they are attached, form a saturated or partially saturated 4 to 7 membered heterocarbocyclic ring containing one nitrogen atom in the ring;
R4 is C1 to C6 alkyl, C3 to C6 cycloalkyl or phenyl;
each R5a and R5b is, independently, C1 to C6 alkyl, C3 to C6 cycloalkyl or phenyl; and
each n and m is, independently, 0, 1, 2 or 3; and
comprising;
(a) providing a compound of Formula II;
whereinR6 is H, a hydroxyl protecting group or a linker connected to a solid support;
R7 is H, hydroxyl, C1-20 alkyl, C3-20 alkenyl, C2-20 alkynyl, halogen, SR7a wherein R7a is selected from hydrogen, a protecting group and substituted or unsubstituted C1-20 alkyl, C3-20 alkenyl, and C2-20 alkynyl;
keto, carboxyl, nitro, nitroso, cyano, trifluoromethyl, trifluoromethoxy, O—
C1-20 alkyl, NH—
C1-20 alkyl, N-diC1-20 alkyl, O-aryl, S-aryl, NH-aryl, O—
C1-20 aralkyl, S—
C1-20 aralkyl, NH—
C1-20 aralkyl, amino, N-phthalimido, imidazolyl, azido, hydrazino, hydroxylamino, isocyanato, aryl, heterocyclyl, carbocyclyl, intercalator, reporter molecule, conjugate, polyamine, polyamide, polyalkylene glycol, polyether, or one of formula XII or XIII;
wherein;
E is C1 to C10 alkyl, N(R15)(R17) and N═
C(R15)R17);
each R15 and R17 is, independently, H, C1 to C10 alkyl, dialkylaminoalkyl, a nitrogen protecting group, a conjugate group, or a linker to a solid support;
or R15 and R17, together, are form a nitrogen protecting group or a ring structure that can include at least one additional heteroatom selected from N and O;
each q1 and q2 is, independently, an integer from 1 to 10;
R16 is OR18, SR18, or N(R18)2;
R18 is H, C1 to C8 alkyl, C1 to C8 haloalkyl, C(═
NH)N(H)R19, C(═
O)N(H)R19 or OC(═
O)N(H)R19;
R19 is H or C1 to C8 alkyl;
L1, L2 and L3 form a ring system having from about 4 to about 7 carbon atoms or having from about 3 to about 6 carbon atoms and 1 or 2 heteroatoms wherein each of said heteroatoms is, independently, oxygen, nitrogen or sulfur and wherein said ring system is aliphatic, unsaturated aliphatic, aromatic, or saturated or unsaturated heterocyclic;
L4 is alkyl or haloalkyl having 1 to about 10 carbon atoms, alkenyl having 2 to about 10 carbon atoms, alkynyl having 2 to about 10 carbon atoms, aryl having 6 to about 14 carbon atoms, N(R15)(R17)OR15, halo, SR15 or CN;
q4 is 0, 1 or 2;
R8 is NR8aR8b, or a 5- or 6-membered heterocyclic system containing 1 to 4 heteroatoms wherein each of said heteroatoms is, independently, N, O or S;
each R8a and R8b is, independently, C1 to C10 alkyl or C3 to C7 cycloalkyl;
X1 is O or S;
each B is, independently, a protected or unprotected naturally occurring nucleobase, or a protected or unprotected non-naturally occurring nucleobase;
q is an integer from 1 to 10;
p is 0 or an integer from 1 to about 50;
each Q is, independently, OH, SH or (b) reacting the compound of Formula II with a compound of Formula III;
wherein;
R10 is a hydroxyl protecting group or a linker connected to a solid support;
with the provisos that R6 and R10 are not both simultaneously a linker connected to a solid support;
p′
is 0 or an integer from 1 to about 50; and
either;
1) at least one n is other than zero and at least one R3a is other than hydrogen wherein one of the central carbons of the group (R3a—
C)n—
C(R3)2 is said chiral atom;
or 2) at least one moiety of Formula X contains a chiral atom;
to form said oligonucleotide compound.
1 Assignment
0 Petitions
Accused Products
Abstract
Novel P(III) bisamidite reagents as phosphorus protecting groups, nucleoside phosphoramidite intermediates, and synthetic processes for making the same are disclosed. Furthermore, oligomeric compounds are prepared through the protection of one or more internucleosidic phosphorus functionalities, preferably followed by oxidation and cleavage of the protecting groups to provide oligonucleotides.
40 Citations
56 Claims
-
1. A method for the preparation of an oligonucleotide compound containing one or more moieties having Formula X:
-
wherein; each W and X is, independently, O or S;
Y is O or NR2;
Z is a single bond, O or NR2a;
each R1 is, independently C1 to C6 alkyl, C2 to C6 alkenyl, C2 to C6 alkynyl, C3 to C6 cycloalkyl, CN, NO2, Cl, Br, F, I, CF3, OR4, NR5aR5b or phenyl;
or two R1 groups, when on adjacent carbons of the phenyl ring, together form a naphthyl ring that includes said phenyl ring;
each R2 and R2a is, independently, H, C1 to C6 alkyl, C2 to C6 alkenyl, C2 to C6 alkynyl, C3 to C6 cycloalkyl or phenyl;
each R3 is, independently, hydrogen, C1 to C6 alkyl, C2 to C6 alkenyl, C2 to C6 alkynyl, C3 to C6 cycloalkyl or phenyl;
or R2 and one R3, together with the atoms to which they are attached, form a saturated or partially saturated 4 to 7 membered, heterocarbocyclic ring containing one nitrogen atom in the ring;
each R3a is, independently, hydrogen, C1 to C6 alkyl, C2 to C6 alkenyl, C2 to C6 alkynyl, C3 to C6 cycloalkyl or phenyl;
or R2 and R3a, together with the atoms to which they are attached, form a saturated or partially saturated 4 to 7 membered heterocarbocyclic ring containing one nitrogen atom in the ring;
R4 is C1 to C6 alkyl, C3 to C6 cycloalkyl or phenyl;
each R5a and R5b is, independently, C1 to C6 alkyl, C3 to C6 cycloalkyl or phenyl; and
each n and m is, independently, 0, 1, 2 or 3; and
comprising;
(a) providing a compound of Formula II;
wherein R6 is H, a hydroxyl protecting group or a linker connected to a solid support;
R7 is H, hydroxyl, C1-20 alkyl, C3-20 alkenyl, C2-20 alkynyl, halogen, SR7a wherein R7a is selected from hydrogen, a protecting group and substituted or unsubstituted C1-20 alkyl, C3-20 alkenyl, and C2-20 alkynyl;
keto, carboxyl, nitro, nitroso, cyano, trifluoromethyl, trifluoromethoxy, O—
C1-20 alkyl, NH—
C1-20 alkyl, N-diC1-20 alkyl, O-aryl, S-aryl, NH-aryl, O—
C1-20 aralkyl, S—
C1-20 aralkyl, NH—
C1-20 aralkyl, amino, N-phthalimido, imidazolyl, azido, hydrazino, hydroxylamino, isocyanato, aryl, heterocyclyl, carbocyclyl, intercalator, reporter molecule, conjugate, polyamine, polyamide, polyalkylene glycol, polyether, or one of formula XII or XIII;
wherein; E is C1 to C10 alkyl, N(R15)(R17) and N═
C(R15)R17);
each R15 and R17 is, independently, H, C1 to C10 alkyl, dialkylaminoalkyl, a nitrogen protecting group, a conjugate group, or a linker to a solid support;
or R15 and R17, together, are form a nitrogen protecting group or a ring structure that can include at least one additional heteroatom selected from N and O;
each q1 and q2 is, independently, an integer from 1 to 10;
R16 is OR18, SR18, or N(R18)2;
R18 is H, C1 to C8 alkyl, C1 to C8 haloalkyl, C(═
NH)N(H)R19, C(═
O)N(H)R19 or OC(═
O)N(H)R19;
R19 is H or C1 to C8 alkyl;
L1, L2 and L3 form a ring system having from about 4 to about 7 carbon atoms or having from about 3 to about 6 carbon atoms and 1 or 2 heteroatoms wherein each of said heteroatoms is, independently, oxygen, nitrogen or sulfur and wherein said ring system is aliphatic, unsaturated aliphatic, aromatic, or saturated or unsaturated heterocyclic;
L4 is alkyl or haloalkyl having 1 to about 10 carbon atoms, alkenyl having 2 to about 10 carbon atoms, alkynyl having 2 to about 10 carbon atoms, aryl having 6 to about 14 carbon atoms, N(R15)(R17)OR15, halo, SR15 or CN;
q4 is 0, 1 or 2;
R8 is NR8aR8b, or a 5- or 6-membered heterocyclic system containing 1 to 4 heteroatoms wherein each of said heteroatoms is, independently, N, O or S; each R8a and R8b is, independently, C1 to C10 alkyl or C3 to C7 cycloalkyl;
X1 is O or S;
each B is, independently, a protected or unprotected naturally occurring nucleobase, or a protected or unprotected non-naturally occurring nucleobase;
q is an integer from 1 to 10;
p is 0 or an integer from 1 to about 50;
each Q is, independently, OH, SH or (b) reacting the compound of Formula II with a compound of Formula III;
wherein; R10 is a hydroxyl protecting group or a linker connected to a solid support;
with the provisos that R6 and R10 are not both simultaneously a linker connected to a solid support;
p′
is 0 or an integer from 1 to about 50; and
either;
1) at least one n is other than zero and at least one R3a is other than hydrogen wherein one of the central carbons of the group (R3a—
C)n—
C(R3)2 is said chiral atom;
or2) at least one moiety of Formula X contains a chiral atom;
to form said oligonucleotide compound.- View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)
with a compound of Formula VI;
in the presence of an acid.
-
-
15. The method of claim 1 wherein the compound of Formula II is obtained by reaction of a compound of Formula V:
-
with a chiorophosphine compound of formula ClP(NR8aR8b)2, followed by reaction with a compound of Formula I-i;
in the presence of an acid.
-
-
16. The method of claim 15 wherein W is O;
- Z is a single bond or NR2a;
each R1 is, independently, CH3, CH2CH3, CH(CH3)2, CN, NO2, OCH3, OCH2CH3, OCH(CH3)2, N(CH3)2, N(CH2CH3)2 or N(CH(CH3)2)2;
each R3 is, independently, H or CH3;
R4 is H;
n is 1 or 2; and
m is 0 or 1.
- Z is a single bond or NR2a;
-
17. The method of claim 1 wherein said compound of formula II comprises at least one chirally pure phosphorus atom.
-
18. A method for the preparation of a compound of Formula II:
-
wherein; each W and X is, independently, O or S;
Y is O or NR2;
Z is a single bond, O or NR2a;
each R1 is, independently C1 to C6 alkyl, C2 to C6 alkenyl, C2 to C6 alkynyl, C3 to C6 cycloalkyl, CN, NO2, Cl, Br, F, I, CF3, OR4, NR5aR5b or phenyl;
or two R1 groups, when on adjacent carbons of the phenyl ring, together form a naphthyl ring that includes said phenyl ring;
each R2 and R2a is, independently, H, C1 to C6 alkyl, C2 to C6 alkenyl, C2 to C6 alkynyl, C3 to C6 cycloalkyl or phenyl;
each R3 is, independently, hydrogen, C1 to C6 alkyl, C2 to C6 alkenyl, C2 to C6 alkynyl, C3 to C6 cycloalkyl or phenyl;
or R2 and one R3, together with the atoms to which they are attached, form a saturated or partially saturated 4 to 7 membered heterocarbocyclic ring containing one nitrogen atom in the ring;
each R3a is, independently, hydrogen, C1 to C6 alkyl, C2 to C6 alkenyl, C2 to C6 alkynyl, C3 to C6 cycloalkyl or phenyl;
or R2 and R3a, together with the atoms to which they are attached, form a saturated or partially saturated 4 to 7 membered heterocarbocyclic ring containing one nitrogen atom in the ring;
R4 is C1 to C6 alkyl, C3 to C6 cycloalkyl or phenyl;
each R5a and R5b is, independently, C1 to C6 alkyl, C3 to C6 cycloalkyl or phenyl; and
each n and m is, independently, 0, 1, 2 or 3; and
R6 is H, a hydroxyl protecting group or a linker connected to a solid support;
R7 is H, hydroxyl, C1-20 alkyl, C3-20 alkenyl, C2-20 alkynyl, halogen, SR7a wherein R7a is selected from hydrogen, a protecting group and substituted or unsubstituted C1-20 alkyl, C3-20 alkenyl, and C2-20 alkynyl;
keto, carboxyl, nitro, nitroso, cyano, trifluoromethyl, trifluoromethoxy, O—
C1-20 alkyl, NH—
C1-20 alkyl, N-diC1-20 alkyl, O-aryl, S-aryl, NH-aryl, O—
C1-20 aralkyl, S—
C1-20 aralkyl, NH—
C1-20 aralkyl, amino, N-phthalimido, imidazolyl, azido, hydrazino, hydroxylamino, isocyanato, aryl, heterocyclyl, carbocyclyl, intercalator, reporter molecule, conjugate, polyamine, polyamide, polyalkylene glycol, polyether, or one of formula XII or XIII;
wherein; E is C1 to C10 alkyl, N(R15)(R17) or N═
C(R15)(R17);
each R15 and R17 is, independently, H, C1 to C10 alkyl, dialkylaminoalkyl, a nitrogen protecting group, a conjugate group, or a linker to a solid support;
or R15 and R17, together, form a nitrogen protecting group or a ring structure that can include at least one additional heteroatom selected from N and O;
each q1 and q2 is, independently, an integer from 1 to 10;
q3 is 0 or 1;
R16 is OR18, SR18, or N(R18)2;
R15 is H, C1 to C8 alkyl, C1 to C8 haloalkyl, C(═
NH)N(H)R19, C(═
O)N(H)R19 or OC(═
O)N(H)R19;
R19 is H or C1 to C8 alkyl;
L1, L2 and L3 form a ring system having from about 4 to about 7 carbon atoms or having from about 3 to about 6 carbon atoms and 2 or 2 heteroatoms wherein each of said heteroatoms is, independently, oxygen, nitrogen or sulfur and wherein said ring system is aliphatic, unsaturated aliphatic, aromatic, or saturated or unsaturated heterocyclic;
L4 is alkyl or haloalkyl having 1 to about 10 carbon atoms, alkenyl having 2 to about 10 carbon atoms, alkynyl having 2 to about 10 carbon atoms, aryl having 6 to about 14 carbon atoms, N(R15)(R17)OR15, halo, SR15 or CN;
q4 is 0, 1 or 2;
R8 is NR8aR8b, or a 5- or 6-membered heterocyclic system containing 1 to 4 heteroatoms wherein each of said heteroatoms is, independently, N, O or S;
each R8a and R8b is, independently, C1 to C10 alkyl or C3 to C7 cycloalkyl;
X1 is O or S;
each B is, independently, a protected or unprotected naturally occurring nucleobase, or a protected or unprotected non-naturally occurring nucleobase;
q is an integer from 1 to 10;
p is 0 or an integer from 1 to about 50;
each Q is, independently, OH, SH or
comprising;
reacting a nucleoside of Formula V;
with a chlorophosphine compound of formula CIP-(R8)2, in the presence of a base; and
protecting the product by reaction with a compound of Formula I-i;
in the presence of an acid to form the compound of Formula II;
with the proviso that structure I-i has a chiral atom wherein one of the central carbons of the group (R3a—
C)n—
C(R3)2 is said chiral atom.- View Dependent Claims (19, 20, 21, 22, 23, 24)
-
-
25. A compound of Formula XI:
-
wherein; each W and X is, independently, O or S;
Y is O or NR2;
Z is a single bond, O or NR2a;
each R1 is, independently C1 to C6 alkyl, C2 to C6 alkenyl, C2 to C6 alkynyl, C3 to C6 cycloalkyl, CN, NO2, Cl, Br, F, I, CF3, OR4, NR5aR5b or phenyl;
or two R1 groups, when on adjacent carbons of the phenyl ring, together form a naphthyl ring that includes said phenyl ring;
each R2 and R2a is, independently, H, C1 to C6 alkyl, C2 to C6 alkenyl, C2 to C6 alkynyl, C3 to C6 cycloalkyl or phenyl;
each R3 is, independently, hydrogen, C1 to C6 alkyl, C2 to C6 alkenyl, C2 to C6 alkynyl, C3 to C6 cycloalkyl or phenyl;
or R2 and one R3, together with the atoms to which they are attached, form a saturated or partially saturated 4 to 7 membered heterocarbocyclic ring containing one nitrogen atom in the ring;
each R3a is, independently, hydrogen, C1 to C6 alkyl, C2 to C6 alkenyl, C2 to C6 alkynyl, C3 to C6 cycloalkyl or phenyl;
or R2 and R3a, together with the atoms to which they are attached, form a saturated or partially saturated 4 to 7 membered heterocarbocyclic ring containing one nitrogen atom in the ring;
R4 is C1 to C6 alkyl, C3 to C6 cycloalkyl or phenyl;
each R5a and R5b is, independently, C1 to C6 alkyl, C3 to C6 cycloalkyl or phenyl; and
R6 is H, a hydroxyl protecting group, or a linker connected to a solid support;
each R7 is, independently, H, hydroxyl, C1 to C20 alkyl, C3 to C20 alkenyl, C2 to C20 alkynyl, halogen, SR7a, wherein R7a is selected from hydrogen, a protecting group and substituted or unsubstituted C1-20 alkyl, C3-20 alkenyl, and C2-20 alkynyl;
keto, carboxyl, nitro, nitroso, cyano, trifluoromethyl, trifluoromethoxy, O-alkyl, NH—
C1-20 alkyl, N—
C1-20 dialkyl, O-aryl, S-aryl, NH-aryl, O—
C1-20 aralkyl, S—
C1-20 aralkyl, NH—
C1-20 aralkyl, amino, N-phthalimido, imidazolyl, azido, hydrazino, hydroxylamino, isocyanato, aryl, heterocyclyl, carbocyclyl, intercalator, reporter molecule, conjugate, polyamine, polyamide, polyalkylene glycol, polyether, or one of formula XII or XIII;
wherein; E is C1 to C10 alkyl, N(R15)(R17) or N═
C(R15)(R17);
each R15 and R17 is, independently, H, C1 to C10 alkyl, dialkylaminoalkyl, a nitrogen protecting group, a conjugate group;
or a linker to a solid support;
or R15 and R17, together, form a nitrogen protecting group or a ring structure that can include at least one additional heteroatom selected from N and O;
each q1 and q2 is, independently, an integer from 1 to 10;
q3 is 0 or 1;
R16 is OR18, SR18, or N(R18)2;
each R18 is, independently, H, C1 to C8 alkyl, C1 to C8 haloalkyl, C(═
NH)N(H)R19, C(═
O)N(H)R19 or OC(═
O)N(H)R19;
R19 is H or C1 to C8 alkyl;
L1, L2 and L3 form a ring system having from about 4 to about 7 carbon atoms or having from about 3 to about 6 carbon atoms and 1 or 2 heteroatoms wherein said heteroatoms are selected from oxygen, nitrogen and sulfur and wherein said ring system is aliphatic, unsaturated aliphatic, aromatic, or saturated or unsaturated heterocyclic;
L4 is alkyl or haloalkyl having 1 to about 10 carbon atoms, alkenyl having 2 to about 10 carbon atoms, alkynyl having 2 to about 10 carbon atoms, aryl having 6 to about 14 carbon atoms, N(R15)(R17)OR15, halo, SR15 or CN; and
q4 is 0, 1 or 2;
R8 is NR8aR8b, or a 5- or 6-membered heterocyclic system containing 1 to 4 heteroatoms wherein each of said heteroatoms is, independently, N, O or S;
each R8a and R8b is, independently, C1 to C10 alkyl or C3 to C7 cycloalkyl;
each n and m is, independently, 0, 1, 2 or 3;
each X1 is, independently, O or S;
each B is, independently, a protected or unprotected naturally occurring nucleobase, or a protected or unprotected non-naturally occurring nucleobase;
each Q is, independently, SH, OH or R10 is H, a hydroxyl protecting group, or a linker connected to a solid support; and
each p and p′
is, independently, 0 or an integer from 1 to about 50;
with the provisos that the sum of p and p′
does not exceed 50, R6 and R10 are not both simultaneously a linker connected to a solid support, and either;
1) at least one n is other than zero and at least one R3a, is other than hydrogen;
or2) the group;
- View Dependent Claims (26, 27, 28, 29, 30, 31, 32)
and p is an integer from 2 to 50.
-
-
32. The compound of claim 25 comprising at least one chirally pure phosphorus atom.
-
33. A compound of Formula VII:
-
wherein; each W and X is, independently, O or S;
Y is O or NR2;
Z is a single bond, O or NR2a;
each R1 is, independently C1 to C6 alkyl, C2 to C6 alkenyl, C2 to C6 alkynyl, C3 to C6 cycloalkyl, CN, NO2, Cl, Br, F, I, CF3, OR4, NR5aR5b or phenyl;
or two R1 groups, when on adjacent carbons of the phenyl ring, together form a naphthyl ring that includes said phenyl ring;
each R2 and R2a is, independently, H, C1 to C6 alkyl, C2 to C6 alkenyl, C2 to C6 alkynyl, C3 to C6 cycloalkyl or phenyl;
each R3 is, independently, hydrogen, C1 to C6 alkyl, C2 to C6 alkenyl, C2 to C6 alkynyl, C3 to C6 cycloalkyl or phenyl;
or R2 and one R3, together with the atoms to which they are attached, form a saturated or partially saturated 4 to 7 membered cyclic structure containing 0, 1, or 2 heteroatoms;
each R3a is, independently, hydrogen, C1 to C6 alkyl, C2 to C6 alkenyl, C2 to C6 alkynyl, C3 to C6 cycloalkyl or phenyl;
or R2 and R3a, together with the atoms to which they are attached, form a saturated or partially saturated 4 to 7 membered cyclic structure containing 0, 1, or 2 heteroatoms;
R4 is C1 to C6 alkyl, C3 to C6 cycloalkyl or phenyl;
each R5a and R5b is, independently, C1 to C6 alkyl, C3 to C6 cycloalkyl or phenyl;
each n and m is, independently, 0, 1, 2 or 3;
A is (R8)2P, R8R11P, R8R12PR11R12P or X3X4P;
X3 is Br, Cl, or I;
X4 is NRaRb, or a 5- or 6-membered heterocyclic system containing 1 to 4 heteroatoms selected from N, O and S;
each R8 is, independently, NR8aR8b, or a 5- or 6-membered heterocyclic system containing 1 to 4 heteroatoms wherein each of said heteroatoms is, independently, N, O or S;
each R8a and R8b is, independently, C1 to C10 alkyl or C3 to C7 cycloalkyl;
R11 is a substituent of Formula VIII;
wherein each R7 is, independently, H, hydroxyl, C1 to C20 alkyl, C3 to C20 alkenyl, C2 to C20 alkynyl, halogen, SR7a wherein R7a is selected from hydrogen, a protecting group and substituted or unsubstituted C1-20 alkyl, C3-20 alkenyl, and C2-20 alkynyl;
keto, carboxyl, nitro, nitroso, cyano, trifluoromethyl, trifluoromethoxy, O—
C1-20 alkyl, NH—
C1-20 alkyl, N-diC1-20 alkyl, O-aryl, S-aryl, NH-aryl, O—
C1-20 aralkyl, S—
C1-20 aralkyl, NH—
C1-20 aralkyl, amino, N-phthalimido, imidazolyl, azido, hydrazino, hydroxylamino, isocyanato, aryl, heterocyclyl, carbocyclyl, intercalator, reporter molecule, conjugate, polyamine, polyamide, polyalkylene glycol, polyether, or one of formula XII or XIII;
wherein; E is C1 to C10 alkyl, N(R15)(R17) or N═
C(R15)(R17);
each R15 and R17 is, independently, H, C1 to C10 alkyl, dialkylaminoalkyl, a nitrogen protecting group, a conjugate group, or a linker to a solid support;
or R15 and R17, together, form a nitrogen protecting group or a ring structure that can include at least one additional heteroatom selected from N and O;
each q1 and q2 is, independently, an integer from 1 to 10;
q3 is 0 or 1;
R16 is OR18, SR18 or N(R18)2;
each R18 is, independently, H, C1 to C8 alkyl, C1 to C8 haloalkyl, C(═
NH)N(H)R19, C(═
O)N(H)R19 or OC(═
O)N(H)R19;
R19 is H or C1 to C8 alkyl;
L1, L2 and L3 form a ring system having from about 4 to about 7 carbon atoms or having from about 3 to about 6 carbon atoms and 1 or 2-heteroatoms wherein said heteroatoms are selected from oxygen, nitrogen and sulfur and wherein said ring system is aliphatic, unsaturated aliphatic, aromatic, or saturated or unsaturated heterocyclic;
L4 is alkyl or haloalkyl having 1 to about 10 carbon atoms, alkenyl having 2 to about 10 carbon atoms, alkynyl having 2 to about 10 carbon atoms, aryl having 6 to about 14 carbon atoms, N(R15)(R17), OR15, halo, SR15 or CN;
q4 is, 0, 1 or 2;
each X1 is, independently, O or S;
each B is, independently, a protected or unprotected naturally occurring nucleobase, or a protected or unprotected non-naturally occurring nucleobase;
R10 is H, a hydroxyl protecting group, or a linker connected to a solid support;
p′
is 0 or an integer from 1 to about 50;
each Q is, independently, SH, OH or R12 is a compound of Formula IX;
wherein; R6 is H, a hydroxyl protecting group, or a linker connected to a solid support; and
p is 0 or an integer from 1 to about 50;
with the provisos that the sum of p and p′
does not exceed 50, when A is PR11R12, R6 and R10 are not both simultaneously a linker connected to a solid support, and either;
1) at least one n is other than zero and at least one R3a is other than hydrogen;
or2) the group;
contains a chiral atom wherein one of the central carbons of the group (R3a—
C)n—
C(R3)2 is said chiral atom.- View Dependent Claims (34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56)
-
Specification